Navigation Links
Takeda Pharmaceuticals Establishes $3 Million Endowment with AGA Foundation
Date:5/17/2008

Gift Will Fund Annual James W. Freston Single Topic Conference Series for

Gastroenterology Research

BETHESDA, Md., May 17 /PRNewswire/ -- The American Gastroenterological Association (AGA) Foundation for Digestive Health and Nutrition (FDHN) announced a gift of $3 million from Takeda Pharmaceuticals to establish The Takeda Endowment Fund within the AGA Foundation's overall endowment. Interest earned from The Takeda Endowment Fund will provide annual support for an AGA Institute Single Topic Conference. The annual conference will be named in honor of former AGA President and past AGA Foundation Chair, James W. Freston, MD, PhD.

"This contribution will make the science of gastroenterology stronger," said AGA FDHN Chair, Sidney Cohen, MD. "We are extraordinarily pleased and appreciative of Takeda's philanthropic investment in the field of gastroenterology. This endowment grant differs from education grants, which while very important, usually represent support for a single event or project. The Takeda Endowment Fund will provide support for the James W. Freston Conferences in perpetuity. Consequently, we are very excited about the long-term positive health outcomes that The Takeda Endowment Fund will foster."

The purpose of the James W. Freston Single Topic Conference is to bring together scientists in the gastrointestinal field to discuss important scientific issues relevant to the practice of gastroenterology. Conference topics will be identified by the Governing Board of the AGA Institute and conference directors will be world-recognized AGA members and scientific leaders within the specialty. Because understanding of basic concepts in medical science often precedes advances in translational research and improvements in patient care, The Takeda Endowment Fund will support efforts to improve patient health in the years ahead.

"Single topic conferences are cutting-edge opportunities to foster discussion, engag
'/>"/>

SOURCE American Gastroenterological Association Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
2. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
3. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
4. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
5. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
(Date:6/2/2015)... June 02, 2015 Through rare discovery ... Yancy Corporation is enabling World Scientists to ... and biological sample, displaying the full nature (position, shape, ... atoms. , Jeff Porter, Co-Founder of the Yancy Corporation, ... that – rare. They come once in a lifetime, ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... on health care, Jack Uldrich has been selected ... in New York today. He will deliver his ... , Uldrich has delivered presentations to the American ... of Audiology and Neurology, Alcetel-Lucent/Verizon Forum on Wireless ...
(Date:6/1/2015)... and RARITAN, N.J. , ... LLC (Janssen) announced data from the Phase 3 ... in progression-free survival (PFS) with trabectedin (YONDELIS ® ... liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated with ... regimen. SAR3007 is the largest randomized Phase 3 ...
Breaking Biology Technology:RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6
... 7 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon" or the ... receipt of preliminary proxies, the Company believes that it has ... ("Merger") by and among Dragon, Chief Respect Limited, Datong Investment ... Yanlin Han . The Merger must be approved by holders ...
... , , ... a 25 percent replacement for petroleum oil more than doubles rubber,s stretchability and reduces its environmental ... Ford,s ... automotive parts such as deflector shields and baffles, radiator deflector shields, cupholder inserts and floor mats ...
... DATATRAK International, Inc. (OTCQX: DATA), a technology and services ... industry, today announced that it privately placed 357,857 common shares ... with certain members of its Board of Directors and management ... are restricted securities and are subject to the restrictions on ...
Cached Biology Technology:Dragon Pharma announces receipt of preliminary proxies to approve merger 2Dragon Pharma announces receipt of preliminary proxies to approve merger 3Ford Pioneers Patent-Pending Use of Eco-Friendly Soy Oil in Rubber Automotive Parts 2Ford Pioneers Patent-Pending Use of Eco-Friendly Soy Oil in Rubber Automotive Parts 3Ford Pioneers Patent-Pending Use of Eco-Friendly Soy Oil in Rubber Automotive Parts 4DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 2DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 3
(Date:5/26/2015)... Research and Markets ( ... "Saudi Arabia Biometric Systems Market Forecast and ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... to grow at over 22% CAGR through 2020 ... the surging demand for better biometric technologies in ...
(Date:5/22/2015)... According to a new market research report ... by Software (Middleware, Databases), by Hardware (Cameras, Integrated Devices), ... - Global Forecast to 2020", published by MarketsandMarkets, Facial ... to $6.19 Billion by 2020, at a CAGR of ... and   43 Figures spread through 140 Pages and ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... Sciences (NAS) and Institute of Medicine (IOM) today released ... the public a comprehensive and up-to-date picture of the ... the science classroom. Recent advances in science and ... over the past 150 years, have reinforced evolution,s role ...
... Springer is launching Tropical Plant Biology, a journal which ... tropical plant biology as well as applications towards genetic ... the growing number of new plant science journals in ... for March 2008. Tropical Plant Biology will cover ...
... Massachusetts Medical School and the Carnegie Institution of Washington ... with Oxford BioMedica (LSE: OXB), a gene therapy ... interference (RNAi) patent rights. The technology ... PhD, and Craig C. Mello, PhD, and their colleagues. ...
Cached Biology News:Scientific evidence supporting evolution continues to grow 2Scientific evidence supporting evolution continues to grow 3Springer launches Tropical Plant Biology 2UMMS and CIW grant key RNAi rights to Oxford Biomedica 2
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
... Analyzer and Sorter) large particle flow cytometers ... flow cytometry to applications that were not ... and sorting. Our instruments are based ... cytometers, but are designed to accommodate much ...
Mouse polyclonal antibody raised against a partial recombinant AGTRAP. NCBI Entrez Gene ID = 57085...
... raised against a partial recombinant ... SF3B2 (NP_006833, 592 a.a. ... protein with GST tag. ... NM_006842 Protein ...
Biology Products: